Tradewinds Capital Management’s Vaxart VXRT Stock Holding History

Tradewinds Capital Management’s Portfolio VXRT Stock Details VXRT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-25	Closed	-$19	–	515
2023 Q1	$19	Buy	+25	New	+$23	﹤0.01%	479

Other funds holding VXRT

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Tradewinds Capital Management's VXRT Position: Q2 2023 in Review

Tradewinds Capital Management sold out of Vaxart (VXRT) in Q2 2023, closing a stake of 25 shares — an estimated $19 sold.

Tradewinds Capital Management first reported a position in VXRT in Q1 2023 and held it in 1 quarter. The position peaked at $19 in Q1 2023. 111 funds tracked by Wall St. Rank hold VXRT as of Q2 2023.

Tradewinds Capital Management reported no remaining Vaxart position as of Q2 2023 after selling out during the quarter.
Tradewinds Capital Management sold 25 Vaxart shares in Q2 2023, an estimated $19.
Tradewinds Capital Management first reported a position in Vaxart in Q1 2023 and held it in 1 quarter.
Tradewinds Capital Management's Vaxart position peaked at $19 in Q1 2023.
111 funds tracked by Wall St. Rank held Vaxart as of Q2 2023.

Based on Tradewinds Capital Management's 13F filing for Q2 2023, filed 20 Jul 2023.